CCL2 and systemic lupus erythematosus: In line with this hypothesis, it has been reported that the expression of the CCL2 on MSCs derived from SLE patients or lupus-like mice is lower than that in healthy or wild-type MSCs and that CCL2 overexpression in MSCs derived from SLE patients restored their immunosuppressive function on B cells [68].